JOSHA
Donate
Author

Ignacio Mastroleo

National Scientific and Technical Research Council (CONICET), BioThera Research Institute for the Philosophy of Translational Medicine, FLACSO collaborating centre of PAHO/WHO

16 Publications

Informing patients of relevant health information and innovations: patient recall or annual physical?
Humanities, Social Sciences and Law
| DOI: 10.17160/josha.5.6.455

Informing patients of relevant health information and innovations: patient recall or annual physical?

F

Felicitas Holzer, Ignacio Mastroleo, Roland Mertelsmann

University of Buenos Aires

Recently the NEJM published an interesting debate on the value of the annual physical (also known as “periodic health examination”) (Goroll 2015). “Today, because of the rapid growth of medical…

1,531
2,852
PDF
Democratic reciprocity model: a justification of continued access to an investigational medicine in clinical research
Humanities, Social Sciences and Law
| DOI: 10.17160/josha.3.7.257

Democratic reciprocity model: a justification of continued access to an investigational medicine in clinical research

I

Ignacio Mastroleo

National Scientific and Technical Research Council (CONICET), BioThera Research Institute for the Philosophy of Translational Medicine, FLACSO collaborating centre of PAHO/WHO

In this paper, Dr. Mastroleo develops a normative model for the obligation of continued access to an investigational medicine towards research subjects from the perspective of social or distributive justice…

1,504
3,027
PDF
Ethics of clinical innovation. Now with video by J. Sugarman
Humanities, Social Sciences and Law
| DOI: 10.17160/josha.3.6.242

Ethics of clinical innovation. Now with video by J. Sugarman

I

Ignacio Mastroleo

National Scientific and Technical Research Council (CONICET), BioThera Research Institute for the Philosophy of Translational Medicine, FLACSO collaborating centre of PAHO/WHO

In this presentation, Dr. Mastroleo defends the view that clinical innovation should be understood, following Levine, as non-validated medical practice. Moreover, he argues that if this is the correct interpretation…

1,498
3,294
PDF
Post-Trial Obligations in the Declaration of Helsinki 2013, 1st Revision
Humanities, Social Sciences and Law
| DOI: 10.17160/josha.2.7.73

Post-Trial Obligations in the Declaration of Helsinki 2013, 1st Revision

I

Ignacio Mastroleo

National Scientific and Technical Research Council (CONICET), BioThera Research Institute for the Philosophy of Translational Medicine, FLACSO collaborating centre of PAHO/WHO

This presentation by Dr. Mastroleo is Revision 1 of the previously published version of September 6, 2015 (DOI: 10.17160/josha.2.6.65) Dr. Ignacio Mastroleo works on human health research ethics. Since Feb…

1,509
5,986
PDF
Post-Trial Obligations in the Declaration of Helsinki 2013
Humanities, Social Sciences and Law
| DOI: 10.17160/josha.2.6.65

Post-Trial Obligations in the Declaration of Helsinki 2013

I

Ignacio Mastroleo

National Scientific and Technical Research Council (CONICET), BioThera Research Institute for the Philosophy of Translational Medicine, FLACSO collaborating centre of PAHO/WHO

Dr. Ignacio Mastroleo works on human health research ethics. Since Feb 2015 he is a member of the Post-Trial Responsibilities Workgroup of the Multi-Regional Clinical Trial (MRCT) Center, at Harvard…

1,522
4,015
PDF
La obligación de continuidad de tratamiento beneficioso hacia los sujetos de investigación
Humanities, Social Sciences and Law
| DOI: 10.17160/josha.2.5.57

La obligación de continuidad de tratamiento beneficioso hacia los sujetos de investigación

I

Ignacio Mastroleo

National Scientific and Technical Research Council (CONICET), BioThera Research Institute for the Philosophy of Translational Medicine, FLACSO collaborating centre of PAHO/WHO

Todos los días se prueban nuevos psicofármacos, tratamientos para el VIH/SIDA o el cáncer, entre otras enfermedades. Algunos de esos tratamientos son lo suficientemente exitosos como para cronificar enfermedades antes…

2,496
10,541
PDF